These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4099281)

  • 1. Thymic hyperplasia in Graves' disease.
    Van Herle AJ; Chopra IJ
    J Clin Endocrinol Metab; 1971 Feb; 32(2):140-6. PubMed ID: 4099281
    [No Abstract]   [Full Text] [Related]  

  • 2. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
    Popoveniuc G; Sharma M; Devdhar M; Wexler JA; Carroll NM; Wartofsky L; Burman KD
    Thyroid; 2010 Sep; 20(9):1015-8. PubMed ID: 20718680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thymic hyperplasia and Graves' disease: a non-fortuitous association. case report and review of literature].
    Desforges-Bullet V; Petit-Aubert G; Collet-Gaudillat C; Cerceau R; Fraleu-Louer B; Meckenstock R; Greder A; Cordoliani Y; Beressi JP
    Ann Endocrinol (Paris); 2011 Sep; 72(4):304-309. PubMed ID: 21777902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [More haste less speed].
    Frei R; Moll C; Kurath J; Krause M
    Ther Umsch; 2006 Dec; 63(12):749-52. PubMed ID: 17133294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of thymic hyperplasia with Basedow's disease].
    Nomori H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Oct; 28(10):1372-5. PubMed ID: 1703252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 7. [Basdowian ophthalmic diseases. Pathogenic role of L-triiodothyronine and of LATS. Therapeutic role of L-thyroxine, of d-thyroxine and of corticoids].
    Mahaux JE; Nagel M
    Brux Med; 1967 Oct; 47(43):1003-16. PubMed ID: 4193087
    [No Abstract]   [Full Text] [Related]  

  • 8. Seronegative myasthenia gravis and Graves' disease. Is there a link?
    Polymeris A; Karoutsou E; Doumouchtsis K
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):254-6. PubMed ID: 22421982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case report of large thymic hyperplasia associated with hyperthyroidism.
    Takami K; Omiya H; Higashiyama M; Maeda J; Okami J; Oda K; Tsujinaka T; Kodama K
    Ann Thorac Cardiovasc Surg; 2009 Dec; 15(6):404-7. PubMed ID: 20081752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM; Zakarija M; D'Amour P; Joasoo A
    N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
    [No Abstract]   [Full Text] [Related]  

  • 11. Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.
    Rajatanavin R; Mahatumarat P; Poochanugool L; Kumpolpunth S; Himathongkam T
    J Med Assoc Thai; 1981 Jan; 64(1):11-8. PubMed ID: 6163837
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymic hyperplasia and its spontaneous resolution with treatment of Graves' hyperthyroidism.
    Shanmugasundaram M; Varadhan L; Katreddy MV; Nayak AU
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27190120
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperplasia of the thymic gland in a patient with Graves' disease.
    Inoue K; Sugio K; Inoue T; Ishida T; Sugimachi K
    Ann Thorac Cardiovasc Surg; 2000 Dec; 6(6):397-400. PubMed ID: 11173355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymic hyperplasia presenting as anterior mediastinal mass in 2 patients with Graves disease.
    Budavari AI; Whitaker MD; Helmers RA
    Mayo Clin Proc; 2002 May; 77(5):495-9. PubMed ID: 12005000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].
    Földes J; Gesztesi E; Takács I
    Orv Hetil; 1970 Dec; 111(52):3067-70. PubMed ID: 4099957
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioimmunological studies on the long-acting thyroid stimulator.
    Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
    Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
    McKenzie JM; McCullagh EP
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE; Burke G
    Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
    [No Abstract]   [Full Text] [Related]  

  • 19. [Simultaneous determination of thyrotropic hormone and long-acting thyroid stimulator in the plasma of patients with Graves' disease].
    Földes J; Gesztesi E; Takács I
    Klin Wochenschr; 1971 May; 49(9):554-7. PubMed ID: 4102376
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudo-myasthenia gravis and thymic hyperplasia in Graves' disease.
    Nicolle MW
    Can J Neurol Sci; 1999 Aug; 26(3):201-3. PubMed ID: 10451743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.